About this trial
The current study is a prospective randomised study Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patient with have chronic periodontitis in the age group between 30-50 years.
Patients having ≥20 teeth.
Patients who are systematically healthy.
Patients with localized pockets with probing depth of ≤ 5mm.
Disqualifiers
Patients who have received any surgical or nonsurgical therapy during past 6months
Pregnant or lactating females.
Use of systemic antibiotics in the past 6 months.
Patient who are not willing to give a written informed consent
Trial design
Parallel
Treatments tested in this trial
Bromelain gel
Drugbromelain gel is prepared from bromelain capsules in laboratory
chlorhexidine gel
Drugchlorhexidine gel is prepared from mouth wash
SRP
Procedure/SurgeryScaling and root planing was done with ultra sonic and hand scaling
Treatment groups
Trial outcomes
Primary outcomes
Probing pocket Depth (PPD)
measured using a UNC-15 probe (university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA
Relative attachment level (RAL)
(university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA)
Secondary outcomes
Plaque Index
measured on the tooth surface using a probe
Gingival index
measured on the tooth surface using a probe
Modified Sulcus Bleeding Index
measured on the tooth surface using a probe
Sponsors and contacts
Click on the lead sponsor to view all of their trials.